Rat Model Market Report 2026

Rat Model Market Overview

• Rat Model market size has reached to $1.75 billion in 2025 • Expected to grow to $2.8 billion in 2030 at a compound annual growth rate (CAGR) of 9.9% • Growth Driver: Surge In Medicine Demand Propelling Rat Model Market Growth • Market Trend: Introduction Of Novel IgA Nephropathy Rat Model To Advance Preclinical Research • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Rat Model Market?

The rat model refers to a process that uses rat functional genes, cells, tissues, and organs. These mouse models are employed to simulate both pathological and healthy conditions of the human immune system. The use of humanized rat models is crucial for preclinical research since they may be used to simulate human disease states, evaluate the effectiveness of compounds, and examine how they affect human proteins. The main types of rat models are knockout, outbred, inbred, hybrid, immunodeficient, and conditioned. A knockout mouse is a laboratory mouse in which scientists have disrupted or replaced a gene to inactivate it, or ‘knocked out’, a gene that was previously present. The services offered are cryopreservation, breeding, re-derivation, genetic testing, quarantine, and others by using nuclear transferase, microinjection, embryonic stem cell, and other technologies for oncology, neurology, immunology, toxicology, and other applications.

What Is The Rat Model Market Growth Forecast?

The rat model market size is expected to see strong growth in the next few years. It will grow to $2.8 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing investment in precision medicine research, rising demand for predictive disease models, expansion of gene-editing applications, growing focus on reducing clinical trial failure rates, increasing adoption of humanized rat platforms. Major trends in the forecast period include increasing use of crispr-based rat models, rising demand for immunodeficient and humanized rats, growing adoption of preclinical disease modeling, expansion of genetic editing technologies, enhanced focus on translational research accuracy.

Global Rat Model Market Segmentation

1) By Type: Knockout, Outbred, Inbred, Hybrid, Immunodeficient, Conditioned 2) By Service: Cryopreservation, Breeding, Re-derivation, Genetic Testing 3) By Application: Oncology, Neurology, Immunology, Toxicology, Other Applications Subsegments: 1) By Knockout: CRISPR Knockout, Traditional Knockout 2) By Outbred: Sprague Dawley, Long-Evans, Wistar 3) By Inbred: Fischer 344, Lewis, Buffalo 4) By Hybrid: F1 Hybrid, F2 Hybrid 5) By Immunodeficient: Nude Rats, SCID Rats 6) By Conditioned: Obese Rats, Diabetic Rats

What Is The Driver Of The Rat Model Market?

The rise in demand for medicines is expected to propel the growth of the rat model market in the coming future. Rat models help researchers to research various medicines as they are easier to feed and smaller in size than other complex mammals, such as primates, and is a more convenient option, as a result, rise in demand for medicines increases the demand for rat models’ market. For instance, in July 2024, according to the National Center for Biotechnology Information, a US-based government agency, in 2023, total medicines spending in the United States increased by 13.6% compared to 2022, reaching $722.5 billion. Therefore, the rise in demand for medicines is driving the rat model industry.

Key Players In The Global Rat Model Market

Major companies operating in the rat model market are Genoway SA, Charles River Laboratories International Inc, Taconic Biosciences Inc, Envigo Ltd, Janvier Labs, Harlan Laboratories Inc, Cyagen Biosciences Inc, Ozgene Pty Ltd, Beijing Biocytogen Co Ltd, Ingenious Targeting Laboratory, Mirimus Inc, Pharmaron Beijing Co Ltd, PolyGene AG, Shanghai Model Organisms Center Inc, Transgenic Inc, Viva Biotech Holdings, WuXi AppTec Co Ltd, Applied StemCell Inc, Transviragen Inc, Biomere, Laboratory Corporation of America Holdings, Horizon Discovery Group PLC, Synthego Corporation, ViGene Biosciences Inc

Global Rat Model Market Trends and Insights

Major companies and preclinical research organizations are focusing on developing specialized nephropathy animal models to better mimic human kidney diseases and accelerate therapeutic discovery. Nephropathy animal models are animals engineered or induced to replicate human kidney diseases for studying disease mechanisms and testing therapies, providing a controlled system to explore renal dysfunction, injury, and treatment responses. For instance, in October 2024, Physiogenex, a France-based preclinical research company, launched its new IgA nephropathy rat model after presenting the model at ASN Kidney Week. Designed to provide researchers with a reliable platform for translational studies, the model exhibits hallmark characteristics of IgA nephropathy, including mesangial IgA deposition and proteinuria, supporting the development of targeted therapies and mechanistic research in kidney disease.

What Are Latest Mergers And Acquisitions In The Rat Model Market?

In November 2023, Scantox A/S, a Denmark-based company specializing in preclinical pharmacology, acquired QPS Austria GmbH for an undisclosed amount. Through this acquisition, Scantox A/S aims to enhance its capabilities in drug discovery, particularly in the areas of neurodegenerative diseases, rare diseases, and mental disorders. QPS Austria GmbH, an Austria-based company specializes in contract research for rat model services.

Regional Outlook

North America was the largest region in the rat model market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global rat model market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Rat Model Market?

The rat model market includes revenues earned by entities by providing services such as DNA preparation, genotyping services, knock-in, or transgenic rat or mouse model creation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.